Proteon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRTO and buy or sell other stocks, ETFs, and their options commission-free!About PRTO
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease.
CEOTimothy P. Noyes, MBA
CEOTimothy P. Noyes, MBA
Employees33
Employees33
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2001
Founded2001
Employees33
Employees33
PRTO Key Statistics
Market cap1.11B
Market cap1.11B
Price-Earnings ratio-3.75
Price-Earnings ratio-3.75
Dividend yield—
Dividend yield—
Average volume953.44K
Average volume953.44K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.82
52 Week high$7.82
52 Week low$2.77
52 Week low$2.77
Stock Snapshot
Proteon Therapeutics(PRTO) stock is priced at $28.69, giving the company a market capitalization of 1.11B. It carries a P/E multiple of -3.75.
On 2025-12-23, Proteon Therapeutics(PRTO) stock opened at —, reached a high of —, and a low of —.
The Proteon Therapeutics(PRTO)'s current trading volume is 0, compared to an average daily volume of 953.44K.
In the last year, Proteon Therapeutics(PRTO) shares hit a 52-week high of $7.82 and a 52-week low of $2.77.
In the last year, Proteon Therapeutics(PRTO) shares hit a 52-week high of $7.82 and a 52-week low of $2.77.